CASP3 and lung carcinoma: A ruthenium biochanin-A compound has also been shown to induce apoptosis and cell cycle arrest in A549 lung cancer cells by activating caspase-3, while downregulating PI3K, TNF-α, TGF-β, and PPARγ in a dose-dependent manner [100].